Abstract: The present invention relates to an immunogenic polypeptide isolated from Mycobacterium avium subspecies paratuberculosis and variants of the polypeptide. The polypeptide and variants may be used in vaccines against Johne's disease and in methods for detection of the disease. Antibodies against the polypeptide or variants may be used in diagnostic tests for Johne's disease. Also included are polynucleotides encoding the polypeptide and variants, and methods for preparing these.

Abstract: The invention relates to a method for producing biodegradable, functionalised polymer particles, and to the use of the same as medicament carriers.

Abstract: The invention relates to a method for producing biodegradable, functionalised polymer particles, and to the use of the same as medicament carriers.

Abstract: The invention relates to an emulsion for protecting oxidisable lipids from oxidative damage and methods of making the same.

Abstract: The invention relates to polymer filaments and methods for their production. In particular, although not exclusively, the invention relates to conducting polymer filaments and their production from solutions of polymerisable oxidizable monomer units.

Abstract: A magnetic assembly for a nuclear magnetic resonance apparatus includes a number of primary permanent magnets 1 disposed in an array about a longitudinal axis, the arrangement and/or characteristics of the plurality of magnets being such so as to create a zone of homogeneous magnetic field at some location along the axis forward of the array (and into the material when provided). A secondary permanent magnet 7 may be located along the longitudinal axis within the array of primary magnets and may be moveable. The primary magnets 1 have a north pole and a south pole with an axis therebetween, and may be arranged such that the axis between the poles is at an angle to the longitudinal axis.

Abstract: The invention provides a vaccine comprising secreted protein derived from Mycobacterium avium subsp paratuberculosis (M. ptb) substantially free of whole organisms of that species either dead or alive. The secreted protein may be obtained from a culture of M. ptb with the microorganisms being removed by centrifugation and subsequent filtration. The vaccine may be used for vaccination against Johne's disease.

Abstract: A cadmium- and zinc-hyperaccumulating subspecies from Thlaspi caerulescens and methods for removing and optionally recovering cadmium and zinc from soil using phytoextracting techniques wherein the subspecies is cultivated on soil containing cadmium and zinc.

Abstract: A cadmium and zinc hyperaccumulating subspecies from Thlaspi caerulescense and methods for removing or recovering cadmium and zinc from soils by cultivating the Thlaspi caerulescense subspecies on soils containing cadmium and zinc.

Abstract: The present invention relates to new processes useful for separating whey proteins from whey protein-containing solutions using a novel anion exchanger which comprises a water insoluble, hydrophilic, water swellable, hydroxy (C2–C4) alkylated and cross-linked regenerated cellulose, derivatized with quaternary amino (QA) groups where the level of substitution of the QA groups is 1.4 milli-equivalents per dry gram of anion exchanger (meq/g) or greater.

Abstract: The present invention is related to a new quaternary amino (QA) anion exchanger comprising QA derivatized, hydroxy (C2-C4) alkylated and cross-linked regenerated cellulose, in which the level of derivitization with the QA-groups is 1.4 milli-equivalents per dry gram (meq/g) or greater.

Abstract: This invention is directed to a process for producing an immunoglobulin enriched whey protein fraction from whey protein solutions. More particularly, it relates to the production of a whey protein fraction enriched in immunoglobulin, and optionally a whey protein isolate, using a cation exchanger under selected conditions. The selected conditions require overloading the cation exchanger with potentially absorbable protein which causes the exchanger to adsorb preferentially whey proteins other than immunoglobulin. The invention is also directed to the products produced by the process of the invention.

Abstract: A preparative method of isolating a preselected whey protein or group of whey proteins from a solution is provided. The method comprises the following steps: (a) contacting a whey protein solution with the preselected ion exchanger for a time and at a temperature sufficient to enable the preselected whey protein to be adsorbed; wherein the whey protein solution has (1) a protein content in the range of about 5% to about 20% by weight, (2) a pH of a preselected level, which is the level at which the preselected whey protein or group of whey proteins selectively binds to the preselected ion exchanger, and (3) a reduced ionic strength; and (b) recovering either or both of the following: (1) the whey protein component adsorbed in step (a), and (2) the breakthrough whey protein component not adsorbed in step (a).

Abstract: The invention relates to a nucleotide sequence which is present at a position adjacent to the 5' end of the reverse sequence complementary to the open reading frame coding for a potential transposase contained in the insertion element IS900 in Mycobacterium paratuberculosis. The nucleotide sequence has promoter functions and contains important signals for the regulation of transcription and translation. The invention also relates to methods for cloning and expressing heterologous proteins using such regulatory sequences, to vectors and transformed host cells containing these sequences, and to immunogenic compositions prepared by expression of nucleotide sequences placed under control of these regulatory sequences.

Abstract: Disclosed are rationally designed mixed mode resins which are useful in recovering a target compound from an aqueous solution and methods for use of such resins. The resins described herein have a hydrophobic character at the pH of binding of the target compound and a hydrophilic and/or electrostatic character at the pH of desorption of the target compound from the resin and are specifically designed to bind the target compound from an aqueous solution at both a low and high ionic strength.

Abstract: Disclosed are methods for the preparation of resins comprising a support matrix having ligands capable of binding a target compound covalently attached thereto through a linking group comprising sulfide, sulfoxide, or sulfone functionality. Specifically, in the disclosed methods, a support matrix comprising ethylenically unsaturated functionality is converted to sulfide linkage by contact with a thiol group under free radical reaction conditions and subsequent optional oxidation of the sulfide to the sulfone or sulfoxide functionality.

Abstract: Disclosed are rationally designed mixed mode resins which are useful in recovering a target compound from an aqueous solution and methods for use of such resins. The resins described herein have a hydrophobic character at the pH of binding of the target compound and a hydrophilic and/or electrostatic character at the pH of desorption of the target compound from the resin and are specifically designed to bind the target compound from an aqueous solution at both a low and high ionic strength.

Abstract: Apparatus for laying seeds includes a towable frame from which one or more blades are supported for cutting a slot in the ground surface below, a seed and fertiliser chute feeds seed into the cut ground surface via a channel formed between the frame and blade(s) and tines which make a horizontal branch cut from the slot. A scraper device continually cleans the blade(s).

Abstract: A mutant strain of Schizosaccharomyces #442 (ATCC46954) requiring both glucose and L-malic acid for growth has been produced which is capable of completely utilizing L-malic acid without substantial depletion of glucose. The mutant strain is known as Schizosaccharomyces malidevorans Rodriguez-Thornton #11 (ATCC20771). The yeast is capable of being used to remove L-malic acid from mediums including both L-malic acid and glucose thus making it possible to remove L-malic acid from juices without affecting sweetness, or from grape juices during wine-making conditions without affecting the quantities of glucose available for alcohol fermentation.The invention extends to juice products and wine made using such mutant strains.